Clinical trials
Phase 1/2 Hematologic Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
| Celgene | 1 |
| CellCentric Ltd. | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Clavis Pharma | 1 |
| Curis, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Glycostem Therapeutics BV | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 17 |
| Leukemia, Myeloid, Acute | 6 |
| Neoplasms | 4 |
| Recurrence | 4 |
| Leukemia | 3 |
| Lymphoma, Non-Hodgkin | 2 |
| Graft vs Host Disease | 1 |
| Immune System Diseases | 1 |
| Immunoproliferative Disorders | 1 |
| Leukemia, Biphenotypic, Acute | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.